NightstaRx Commences first Phase I/II Gene Therapy Clinical Trial … – Business Wire (press release)
|
NightstaRx Commences first Phase I/II Gene Therapy Clinical Trial …
Business Wire (press release) NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, tod. |
The Sun |
Brit scientists testing ‘groundbreaking’ therapy that could cure common cause of blindness
The Sun Last Thursday a 29-year-old man with XLRP became the first patient to undergo the gene therapy procedure at Oxford Eye Hospital. A virus carries corrective DNA into cells at the back of the eye. For the treatment to work scientists have to reprogramme … |
Huffington Post UK |
Sexuality Prevents Me From Donating Blood, But Not Stem Cells
Huffington Post UK As Michael Fabricant MP and others helped the gay blood ban become an issue of public interest again in 2014, I looked again at stem cell donation and the Anthony Nolan register. I signed straight up, sent back my ‘spit sample’, and that was that. |